Key Takeaways
- H1 exports deferred, H2 rebound promised: ₹45 crores of exports slipped from H1 to H2 on customer inspection delays, compressing EBITDA margin to 16%. Management calls H2 "one of the best in company's history" as those shipments convert.
- Name change signals ambition beyond glass: The proposed shift to Standard Engineering Technology Ltd, plus two acquisitions, recasts the company as a concept-to-commissioning precision engineering firm, not just an equipment maker.
- Heat exchanger is the growth engine, and it is sold out: 45 shell-and-tube glass-lined units shipped in H1 from Japan; the order book is closed until March while Indian manufacturing capacity is built for 200–300 units next year.
- Small pharma clients are still missing: Big pharma capex drives all the growth; small clients (sub-₹500 Cr revenue) have not added capacity for 2–3 years. If they return, demand turns "blockbuster," but no timeline is offered.
- What to watch next quarter: Whether the ₹45 crores of deferred exports actually ship, the pace of heat exchanger capacity build-out, and any sign that small pharma clients are restarting capex.
The H1 Margin Miss: A Timing Problem, Not a Demand Problem
- The mechanics: EBITDA margin fell from 20% to 16% YoY because ₹45 crores of export equipment was manufactured and costed in H1 but customer inspections were postponed, so dispatch and revenue recognition shifted to H2. The company frames this as a scheduling artifact, not a structural margin reset.
- The recovery bet: Those deferred exports are expected to ship in Q3 and Q4, which management says will "slightly increase" H2 margins above the H1 run-rate of 18.5–18.8%. The full-year export mix is guided at 12–13% of revenue.
- Solution mix supports margins structurally: The company earns a premium on complete solutions versus standalone equipment, and 80% of revenue comes from pharma clients who pay for CGMP and high-compliance manufacturing. That pricing power is the counterweight to any mix shift toward lower-margin product sales.
Nageswara Rao Kandula: "Whenever you provide the complete solution to client, you always will get better price. Not only comparing with the equipment-to-equipment, and the solution versus equipment. We are providing solution."
The Strategic Pivot: From Glass Lining to Precision Engineering
- Name change proposed: Shareholder approval will be sought to rename the company Standard Engineering Technology Limited, dropping "Glass Lining" to reflect a broader identity.
- Two acquisitions fill the design gap: Seismic Private Equipment adds bioprocess and fermentation systems; C2C Engineering (51% for ₹12.25 crores) brings 130 engineers and intellectual design capability across process, mechanical, civil, HVAC, electrical and instrumentation. Together they create an end-to-end chain: design, manufacture, execute, commission, and run water trials.
- The moat claim: Management asserts no other company globally combines multi-disciplinary engineering design with in-house manufacturing and commissioning under one roof. That integration, not any single product, is the pricing-power story.
Nageswara Rao Kandula: "Many equipment -- independent equipment manufacturers are there, they don't have engineering companies, they don't have commissioning, water trials, capacity companies. We have complete manufacturing, engineering, execution, up to water trials. That's the reason we have become a unique precision engineering company."
Heat Exchangers: The Product That Could Reshape the P&L
- The technology: Shell-and-tube glass-lined heat exchangers, developed with Japanese partner GL Hakko, offer a 15-year life versus 2 years for graphite alternatives, and are particle-free, solving a contamination problem pharma and chemical clients have lived with for lack of options.
- Early traction: 45 units were imported from Japan and sold in H1. The order book is now closed: the Japan plant is at capacity, and the company will not accept new orders until Indian manufacturing begins after March.
- Capacity ramp: An exclusive facility is being built for an initial 300 units per year, with plans to scale based on market acceptance. Management expects this product alone to make the company the largest glass-lined equipment manufacturer within two years.
- The unanswered math: When an analyst questioned how 300 units per year addresses a claimed ₹2,000 crores market, management did not reconcile the numbers, saying only that capacity will increase with demand.
Nageswara Rao Kandula: "Graphite heat exchanger life is two years, this heat exchanger life is 15 years. And also graphite heat exchanger releases particles and this is complete particle free. Customer don't want to use graphite, but unfortunately, they don't have option, that's the reason they are using."
Demand Landscape: Big Pharma Carries the Load
- Big pharma is spending: Large clients have announced significant capex programs over the next 2–3 years, and their demand is intact. The company attributes its growth trajectory entirely to this segment.
- Small pharma is absent: Clients below ₹500 crores in revenue have not added capacity for 2–3 years, squeezed by cash flow constraints and price pressure. These buyers historically added 10–12 reactors annually without active marketing; now they add none. Management says their return would create "blockbuster demand" but offers no timeline.
- Agrochemicals turning: Two large agrochemical clients were recently added who were not previously buying from the company, and the sector's requirements are "slowly picking up." SRF orders are in the pipeline with deliveries expected in H2.
- Chemicals improving: The broader chemicals segment is showing improvement, though no quantification was provided.
Nageswara Rao Kandula: "Our growth, all top big clients, due to big clients only we are growing very fast. But once this turned up into small clients also start the capex, then going to blockbuster demand."
Capacity, Capex, and the Path to ₹2,000 Crores
- Current utilization: After adding Unit 5 six months ago, overall capacity utilization stands at 70%. Automation investments now underway are expected to raise the effective capacity of existing facilities, which management says can reach a ₹2,000 crores top line without new buildings.
- New facility on deck: A 36-acre, 6-lakh-square-foot greenfield with 100-ton crane capacity and 100 mm fabrication capability is planned. Land is acquired; government permissions are expected within a week. Once received, a ₹120–150 crores capex program begins, with a 14–18 month timeline to go live. That facility alone adds another ₹2,000 crores of revenue capacity.
- Growth rate anchored: Management commits to a minimum 20–25% annual growth, sustained year on year, and says FY28 onwards will see acceleration. No specific year is given for reaching ₹3,000 crores.
- Order book snapshot: After initially declining to disclose, management offered an approximate figure of ₹750–800 crores, split roughly 30% glass-lined, 30% metal, and 40% plant and engineering solutions.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Deferred export conversion | ₹45 crores of H1-deferred exports to ship | H2 FY26 (Q3/Q4) |
| H2 margin trajectory | H1 EBITDA margins (18.5–18.8%) to sustain or slightly increase as exports ship | H2 FY26 |
| Full-year export mix | Exports at 12–13% of revenue | FY26 |
| Annual revenue growth | Minimum 20–25% YoY growth | FY26 and continuing |
| Heat exchanger order book | Resume accepting new orders after India manufacturing begins | Post-March |
| Heat exchanger capacity | Initial phase: 300 units per year from India facility | FY27 (next year April onwards) |
| New greenfield facility | ₹120–150 crores capex; 14–18 months to go live | Permissions expected next week; live by mid-FY28 |
| Revenue capacity ceiling | Existing facilities: ₹2,000 crores; new facility adds another ₹2,000 crores | Existing now; new facility post-construction |
| Next manufacturing unit | One more unit to start | 16–18 months |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Total income (H1 FY26) | ₹366 cr |
| EBITDA (H1 FY26) | ₹69 cr |
| PAT (H1 FY26) | ₹42 cr |
| EBITDA margin | 16%, declined from 17% QoQ and 20% YoY due to export deferment |
| Revenue growth guidance (FY26) | 20% to 25% |
| Export revenue share (Q2 FY26) | 2.5%, impacted by shipment deferrals to H2 |
| Full-year export revenue guidance | 12% to 13% |
| Deferred exports (H1 to H2 FY26) | ₹45 cr |
| Order book | ₹750 cr to ₹800 cr |
| Order book split | ~30% glass lining, ~30% metal division, ~40% plant and engineering |
| Revenue split | 35% glass lining, rest metal equipment |
| Capacity utilization (overall) | 70% after Unit 5 addition |
| Capacity utilization (glass lining) | 50% |
| Capacity utilization (metal division) | 70% |
| Top 10 client revenue concentration | 45% |